NASDAQ
Impel Pharmaceuticals Inc. (IMPL) has a current ratio of 3.60x as of Monday, May 25, 2026. This represents a 5.68% decrease compared to its 12-month average of 3.82x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.